|
MSDS Letter (PDF)
|
Products that do not require MSDS
|
|
ACZONE® (PDF)
|
ACZONE® (Dapsone) Gel, 5%
|
|
ALPHAGAN® (PDF)
|
(Brimonidine Tartrate Ophthalmic Solution) 0.2%
|
|
ALPHAGAN® P (PDF)
|
(Brimonidine Tartrate Ophthalmic Solution), 0.10% and 0.15%
|
|
AVAGE® (PDF)
|
Tazarotene Cream 0.10%
|
|
AZELEX® (PDF)
|
(Azelaic Acid) 20% Cream
|
|
BETAGAN® (PDF)
|
(Levobunolol HCl Ophthalmic Solution) 0.25% and 0.5%
|
|
BOTOX® (PDF)
|
Botulinum Toxin Type A) Purified Neurotoxin (50, 100 and 200 Units)
|
|
COMBIGAN™ (PDF)
|
(Brimonidine Tartrate, 0.2%/Timolol, 0.5%)Ophthalmic Solution
|
|
ELIMITE® (PDF)
|
(Permethrin) 5% Dermal Cream
|
|
ESTRASORB® (PDF)
|
Estradiol Topical Emulsion
|
|
FLUOROPLEX® (PDF)
|
(Fluorouracil) 1% Topical Cream
|
|
FLUOROPLEX® (PDF)
|
(Fluorouracil) 1% Solution
|
|
GANFORT™ (PDF)
|
(Bimatoprost 0.03%/Timolol 0.5%) Ophthalmic Solution
|
|
Levobunolol (PDF)
|
HCl Sterile Ophthalmic Solution, 0.25% and 0.5%
|
|
M.D. FORTÉ® (PDF)
|
Glycare Perfection Gel
|
|
M.D. FORTÉ® (PDF)
|
Perfection Gel Acne Medication (092)
|
|
M.D. FORTÉ® (PDF)
|
Skin Rejuvenating Hydra-Masque (454)
|
|
M.D. FORTÉ® I (PDF)
|
Glycare (404)
|
|
M.D. FORTÉ® I (PDF)
|
Glycolic Chemical Peel Gel (420)
|
|
M.D. FORTÉ® I (PDF)
|
Skin Cleansing & Prepping Solution
|
|
M.D. FORTÉ® II (PDF)
|
Glycare
|
|
M.D. FORTÉ® II (PDF)
|
Glycolic Chemical Peel Gel (422)
|
|
M.D. FORTÉ® II (PDF)
|
Skin Cleansing & Prepping Solution (418)
|
|
TAZORAC® (PDF)
|
(Tazarotene Cream) 0.05% and 0.10%
|
|
TAZORAC® (PDF)
|
(Tazarotene Gel) 0.05% and 0.10%
|
|
Timolol (PDF)
|
Maleate Ophthalmic Solution, 0.25% and 0.5%
|
|
TRIVARIS™ (PDF)
|
(Triamcinolone Acetonide Injectable Suspension), 80 mg/mL
|
|
VIVITÉ® (PDF)
|
Glycolic Chemical Facial Peel Gel
|
|
VIVITÉ® (PDF)
|
Skin Cleansing and Prepping Solution
|